1162501

ダナゾール

United States Pharmacopeia (USP) Reference Standard

• 別名: 17β-ヒドロキシ-2,4,17α-プレグナジエン-20-yno[2,3-d]イソオキサゾール, 2,4,17α-プレグナジエン-20-イノ[2,3-d]イソオキサゾール-17-オール
• 実験式（ヒル表記法）: C₂₂H₂₇NO₂
• CAS番号: 17230-88-5
• 分子量: 337.46
• MDL番号: MFCD00056838
• UNSPSCコード: 41116107
• PubChem Substance ID: 329749513
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: danazol
• メーカー／製品名: USP
• 薬剤管理: regulated under CDSA - not available from Sigma-Aldrich Canada
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• SMILES記法: CC12Cc3cnoc3C=C1CCC4C2CCC5(C)C4CC[C@@]5(O)C#C
• InChI: 1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16?,17?,18?,20?,21?,22-/m0/s1
• InChI Key: POZRVZJJTULAOH-ZIKCMSSPSA-N

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Danazol USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Danazol Capsules

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS07
• シグナルワード: Warning
• 危険有害性情報: H312 + H332,H361
• 注意書き: P201 - P280 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313
• 危険有害性の分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Repr. 2
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable